• Baijin Life Science Holdings will hold its 2026 annual general meeting in Kowloon Bay, Hong Kong on Sept. 16, 2026.
• Shareholders will vote on re-electing Cheung Sze Ming, Dong Peng, Su Yaoyao, Shen Ding as directors, with board-set remuneration.
• Auditor mandate up for renewal, with Baker Tilly Hong Kong to be re-appointed and its fees set by the board.
• Resolutions include a general share-issuance mandate capped at 20% of outstanding shares, with authority to grant convertible securities.
• Company also seeks a 10% share buyback mandate, an issuance-mandate extension tied to repurchases, and a 10% refreshed 2024 Share Option Scheme limit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baijin Life Science Holdings Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260820-12292179), on August 20, 2026, and is solely responsible for the information contained therein.